GNLX RSI Chart
Last 7 days
-4.2%
Last 30 days
1.4%
Last 90 days
-53.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 8.3M | 5.6M | 2.9M | 170.0K |
2022 | 0 | 0 | 0 | 11.1M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 08, 2024 | szalay aladar | sold | -53,188 | 3.8213 | -13,919 | - |
May 07, 2024 | szalay aladar | sold | -22,111 | 3.6699 | -6,025 | - |
May 01, 2024 | szalay aladar | sold | -109,161 | 3.3018 | -33,061 | - |
Apr 30, 2024 | szalay aladar | sold | -63,980 | 3.1157 | -20,535 | - |
Apr 29, 2024 | szalay aladar | sold | -20,792 | 3.2473 | -6,403 | - |
Apr 24, 2024 | szalay aladar | sold | -28,250 | 3.5033 | -8,064 | - |
Apr 23, 2024 | szalay aladar | sold | -76,799 | 3.4909 | -22,000 | - |
Apr 22, 2024 | szalay aladar | sold | -50,597 | 3.5306 | -14,331 | - |
Apr 17, 2024 | szalay aladar | sold | -84,424 | 3.7131 | -22,737 | - |
Apr 16, 2024 | szalay aladar | sold | -171,802 | 3.529 | -48,683 | - |
Which funds bought or sold GNLX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -37.2 | -30,454 | 12,333 | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -51.47 | -116,000 | 34,000 | -% |
May 15, 2024 | DEUTSCHE BANK AG\ | added | 3.13 | -50,425 | 45,319 | -% |
May 15, 2024 | STATE STREET CORP | added | 4.66 | -2,748,030 | 2,539,950 | -% |
May 15, 2024 | WELLINGTON MANAGEMENT GROUP LLP | sold off | -100 | -360,996 | - | -% |
May 15, 2024 | MORGAN STANLEY | reduced | -4.15 | -485,803 | 381,543 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | added | 102 | -23,069 | 307,385 | -% |
May 15, 2024 | BARCLAYS PLC | reduced | -47.27 | -271,000 | 86,000 | -% |
May 15, 2024 | OCCUDO QUANTITATIVE STRATEGIES LP | new | - | 80,690 | 80,690 | 0.01% |
May 15, 2024 | Walleye Capital LLC | new | - | 65,573 | 65,573 | -% |
Unveiling GENELUX CORPORATION's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to GENELUX CORPORATION)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
GENELUX CORPORATION News
Income Statement (Quarterly) | ||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 |
Revenue | - | - | - | 2,200 | 4,400 | 6,600 | 8,800 | 11,000 |
Operating Expenses | 16.0% | 8,123 | 7,001 | 5,307 | 5,395 | 6,632 | 3,162 | 4,656 |
S&GA Expenses | -100.0% | - | 2,841 | 2,488 | 2,452 | 3,787 | 694 | 2,242 |
R&D Expenses | -3.6% | 4,010 | 4,160 | 2,819 | 2,943 | 2,845 | 2,468 | 2,414 |
Interest Expenses | - | - | - | 22.00 | - | 50.00 | 40.00 | 39.00 |
Income Taxes | - | - | - | - | - | - | - | 1,100 |
Earnings Before Taxes | - | - | - | -5,345 | - | - | - | 6,009 |
Net Income | -16.0% | -7,850 | -6,767 | -5,345 | -5,821 | -10,364 | -3,495 | 4,909 |
Net Income Margin | 8.9% | -151.66* | -166.45* | -8.65* | -2.63* | -1.41* | -0.47* | - |
Free Cashflow | 38.7% | -4,384 | -7,153 | -3,634 | -5,814 | -4,699 | -1,518 | -2,503 |
Balance Sheet | |||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 |
Assets | -11.5% | 24,676 | 27,893 | 34,072 | 31,363 | 14,616 | 5,531 |
Current Assets | -12.4% | 21,204 | 24,203 | 31,179 | 28,683 | 12,056 | 1,892 |
Cash Equivalents | -56.9% | 4,061 | 9,418 | 29,869 | 27,140 | 10,338 | 397 |
Net PPE | -4.6% | 1,116 | 1,170 | 1,022 | 878 | 617 | 644 |
Liabilities | 13.9% | 9,592 | 8,420 | 10,044 | 9,107 | 11,925 | 41,314 |
Current Liabilities | 19.1% | 7,805 | 6,554 | 8,755 | 7,878 | 10,543 | 31,626 |
Long Term Debt | - | - | - | - | - | - | 8,524 |
LT Debt, Non Current | - | - | - | - | - | - | 8,524 |
Shareholder's Equity | -22.5% | 15,084 | 19,473 | 24,028 | 22,256 | 2,691 | -35,783 |
Retained Earnings | -3.5% | -229,374 | -221,524 | -214,757 | -209,412 | -203,591 | -189,784 |
Additional Paid-In Capital | 1.4% | 244,869 | 241,389 | 239,189 | 232,073 | 206,688 | 154,401 |
Shares Outstanding | 0.3% | 26,865 | 26,789 | 26,658 | 25,856 | 24,553 | 9,127 |
Cashflow (Quarterly) | ||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Cashflow From Operations | 37.0% | -4,354 | -6,910 | -3,357 | -5,418 | -4,590 | -1,518 | -2,470 | -2,408 | 2,825 |
Share Based Compensation | -2.9% | 1,489 | 1,533 | 515 | 240 | 227 | 43.00 | 1,703 | 297 | 372 |
Cashflow From Investing | 87.9% | -1,691 | -13,942 | -277 | -396 | -109 | - | -33.00 | -1.00 | -15.00 |
Cashflow From Financing | 71.6% | 688 | 401 | 6,363 | 22,616 | 14,640 | 545 | -329 | -564 | -130 |
Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenues | $ 8 | $ 170 |
Operating expenses: | ||
Research and development | 4,010 | 2,845 |
General and administrative | 4,113 | 3,787 |
Total operating expenses | 8,123 | 6,632 |
Loss from operations | (8,115) | (6,462) |
Other income (expenses): | ||
Interest income | 265 | |
Interest expense | (143) | |
Debt discount amortization | (649) | |
Financing costs | (3,110) | |
Total other income (expenses), net | 265 | (3,902) |
NET LOSS | $ (7,850) | $ (10,364) |
LOSS PER COMMON SHARE - BASIC | $ (0.29) | $ (0.53) |
LOSS PER COMMON SHARE - DILUTED | $ (0.29) | $ (0.53) |
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING - BASIC | 26,849,737 | 19,575,631 |
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING - DILUTED | 26,849,737 | 19,575,631 |
Condensed Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current Assets | ||
Cash and cash equivalents | $ 4,061 | $ 9,418 |
Short-term investments | 15,566 | 13,773 |
Prepaid expenses and other current assets | 1,577 | 1,012 |
Total Current Assets | 21,204 | 24,203 |
Property and equipment, net | 1,116 | 1,170 |
Right of use assets | 2,264 | 2,428 |
Other assets | 92 | 92 |
Total Other Assets | 3,472 | 3,690 |
TOTAL ASSETS | 24,676 | 27,893 |
Current Liabilities | ||
Accounts payable and accrued expenses | 5,313 | 3,784 |
Accrued payroll and payroll taxes | 1,908 | 2,117 |
Lease liabilities, current portion | 584 | 653 |
Total Current Liabilities | 7,805 | 6,554 |
Lease liabilities, long-term portion | 1,787 | 1,866 |
Total Liabilities | 9,592 | 8,420 |
Shareholders’ Equity | ||
Preferred stock, par value $0.001, 10,000,000 shares authorized; no shares issued and outstanding, respectively; | ||
Common stock, par value $0.001, 200,000,000 shares authorized; 26,996,740 and 26,788,986 shares issued and outstanding, respectively | 27 | 27 |
Treasury stock, 433,333 shares, at cost | (433) | (433) |
Additional paid-in capital | 244,869 | 241,389 |
Accumulated other comprehensive income (loss) | (5) | 14 |
Accumulated deficit | (229,374) | (221,524) |
Total Shareholders’ Equity | 15,084 | 19,473 |
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ 24,676 | $ 27,893 |